{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:18:53Z","timestamp":1790065133366,"version":"4.0.1"},"reference-count":344,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ymgme.2014.02.013","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T22:46:55Z","timestamp":1394232415000},"page":"87-122","source":"Crossref","is-referenced-by-count":221,"title":["Phenylketonuria Scientific Review Conference: State of the science and future research needs"],"prefix":"10.1016","volume":"112","author":[{"given":"Kathryn M.","family":"Camp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Parisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyllis B.","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard T.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Bilder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf A.","family":"Bodamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Brosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7724-137X","authenticated-orcid":false,"given":"Alberto B.","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara K.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine S.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven F.","family":"Dobrowolski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne M.","family":"Frazier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy K.","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol L.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Groft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary O.","family":"Harding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7776-9123","authenticated-orcid":false,"given":"R. Rodney","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen L.","family":"Huntington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta D.","family":"Hyatt-Knorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indira P.","family":"Jevaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey L.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Lichter-Konecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Lou","family":"Lindegren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5813-7064","authenticated-orcid":false,"given":"Michele A.","family":"Lloyd-Puryear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberlee","family":"Matalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"McPheeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-6858","authenticated-orcid":false,"given":"John J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shideh","family":"Mofidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn D.","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Mulberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lata S.","family":"Nerurkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth N.","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne R.","family":"Pariser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyash","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pridjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja A.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma M.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances J.","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani H.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1630-651X","authenticated-orcid":false,"given":"Sandra M.","family":"Sirrs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie E.","family":"Stremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo A.","family":"Tagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina K.","family":"Urv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine R.","family":"Utz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francjan","family":"van Spronsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Vockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Waisbren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Weglicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e A.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester B.","family":"Whitley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin S.","family":"Wilfond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yannicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2014.02.013_bb0005","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1542\/peds.108.4.972","article-title":"National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16\u201318, 2000","volume":"108","author":"National Institutes of Health Consensus Development Panel","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/bchm2.1934.227.1-4.169","article-title":"\u00dcber ausscheidung von pheynylbrenztraubens\u00e4ure in den harn als stoffwechselanomalie in verbindung mit imbezillit\u00e4t. (Urinary excretion of phenylpyruvic acid as a metabolic anomaly related to mental retardation.)","volume":"227","author":"F\u00f6lling","year":"1934","journal-title":"Hoppe Seylers Z. Physiol. Chem."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0015","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0140-6736(53)90473-5","article-title":"Influence of phenylalanine intake on phenylketonuria","volume":"265","author":"Bickel","year":"1953","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ymgme.2012.07.005","article-title":"Nutritional treatment for inborn errors of metabolism: indications, regulations, and availability of medical foods and dietary supplements using phenylketonuria as an example","volume":"107","author":"Camp","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1542\/peds.32.3.338","article-title":"A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants","volume":"32","author":"Guthrie","year":"1963","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0030","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1542\/peds.60.6.822","article-title":"Intellectual assessment of 111 four-year-old children with phenylketonuria","volume":"60","author":"Dobson","year":"1977","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10545-007-0690-z","article-title":"Newborn screening in North America","volume":"30","author":"Therrell","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0040","series-title":"Children, Recommended Uniform Screening Panel","author":"D.A.C.o.H.D.i.N.a.","year":"2013"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1020158631102","article-title":"Phenylketonuria in adulthood: a collaborative study","volume":"25","author":"Koch","year":"2002","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0050","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1542\/peds.112.S4.1523","article-title":"The Maternal Phenylketonuria International Study: 1984\u20132002","volume":"112","author":"Koch","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ymgme.2013.05.008","article-title":"Expanding research to provide an evidence base for nutritional interventions for the management of inborn errors of metabolism","volume":"109","author":"Camp","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10545-011-9283-y","article-title":"Mild hyperphenylalaninemia: to treat or not to treat","volume":"34","author":"van Spronsen","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ymgme.2011.05.007","article-title":"Non-PKU mild hyperphenylalaninemia (MHP)\u2014the dilemma","volume":"104","author":"Hanley","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0070","article-title":"Adjuvant treatment for phenylketonuria (PKU)","volume":"No. 56","author":"Lindegren","year":"2012"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/8904_2012_168","article-title":"A systematic review of BH4 (sapropterin) for the adjuvant treatment of phenylketonuria","volume":"8","author":"Lindegren","year":"2013","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0080","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10545-012-9564-0","article-title":"Estimating the probability of IQ impairment from blood phenylalanine for phenylketonuria patients: a hierarchical meta-analysis","volume":"36","author":"Fonnesbeck","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jclinepi.2009.03.009","article-title":"AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions\u2014Agency for Healthcare Research and Quality and the effective health-care program","volume":"63","author":"Owens","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0090","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jama.283.6.756","article-title":"Outcome at age 4years in offspring of women with maternal phenylketonuria: the Maternal PKU Collaborative Study","volume":"283","author":"Waisbren","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0095","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1542\/peds.112.S4.1537","article-title":"Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study","volume":"112","author":"Widaman","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0100","first-page":"181","article-title":"Systematic review of large neutral amino acids for treatment of phenylketonuria","volume":"3","author":"Lindegren","year":"2013","journal-title":"J. Pediatr. Biochem."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10545-007-0462-9","article-title":"Peak bone mass in patients with phenylketonuria","volume":"30","author":"Modan-Moses","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0110","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPG.0b013e3182093b32","article-title":"Impact of metabolic control on bone quality in phenylketonuria and mild hyperphenylalaninemia","volume":"52","author":"Porta","year":"2011","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0115","first-page":"433","article-title":"The implication of phenylketonuria on oral health","volume":"21","author":"Kilpatrick","year":"1999","journal-title":"Pediatr. Dent."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ymgme.2012.01.006","article-title":"Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients","volume":"105","author":"de Groot","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","article-title":"Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence","volume":"101","author":"Enns","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0130","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1532-5415.2008.01870.x","article-title":"Self-reported dietary intake of omega-3 fatty acids and association with bone and lower extremity function","volume":"57","author":"Rousseau","year":"2009","journal-title":"J. Am. Geriatr. Soc."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2014.02.013_bb0135","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1007\/s10545-010-9189-0","article-title":"Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density","volume":"33","author":"Lage","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0140","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.ymgme.2011.09.036","article-title":"Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across development","volume":"104","author":"van Spronsen","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0145","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1651-2227.2003.tb00834.x","article-title":"Do adult patients with phenylketonuria improve their quality of life after introduction\/resumption of a phenylalanine-restricted diet?","volume":"92","author":"Gassio","year":"2003","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0150","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0140-6736(90)93401-A","article-title":"Neurological deterioration in young adults with phenylketonuria","volume":"336","author":"Thompson","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0155","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00234-009-0574-z","article-title":"Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria","volume":"51","author":"Manara","year":"2009","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0160","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10545-006-0399-4","article-title":"The pathogenesis of the white matter abnormalities in phenylketonuria. A multimodal 3.0Tesla MRI and magnetic resonance spectroscopy (1H MRS) study","volume":"30","author":"Leuzzi","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0165","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ymgme.2009.10.005","article-title":"White matter pathology in phenylketonuria","volume":"99","author":"Anderson","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0170","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","article-title":"Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses","volume":"99","author":"de Groot","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0175","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0180","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neubiorev.2008.11.001","article-title":"Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis","volume":"33","author":"Albrecht","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2008.06.014","article-title":"Stability of blood phenylalanine levels and IQ in children with phenylketonuria","volume":"95","author":"Anastasoaie","year":"2008","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0190","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11065-007-9021-2","article-title":"Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU","volume":"17","author":"Moyle","year":"2007","journal-title":"Neuropsychol. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0195","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ymgme.2009.10.009","article-title":"Beyond executive function: non-executive cognitive abilities in individuals with PKU","volume":"99","author":"Janzen","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0200","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.ymgme.2009.10.007","article-title":"Executive function in early-treated phenylketonuria: profile and underlying mechanisms","volume":"99","author":"Christ","year":"2010","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0205","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.ymgme.2009.10.183","article-title":"Psychosocial aspects of PKU: hidden disabilities\u2014a review","volume":"99","author":"Gentile","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pediatrneurol.2005.05.003","article-title":"School performance in early and continuously treated phenylketonuria","volume":"33","author":"Gassio","year":"2005","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0215","first-page":"35","article-title":"Intellectual development in 12-year-old children treated for phenylketonuria","volume":"145","author":"Azen","year":"1991","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0220","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1203\/00006450-200206000-00017","article-title":"Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics","volume":"51","author":"Feldmann","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:BOLI.0000028725.37345.62","article-title":"Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria","volume":"27","author":"Arnold","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0230","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ymgme.2009.10.182","article-title":"Psychiatric symptoms and disorders in phenylketonuria","volume":"99","author":"Brumm","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1542\/peds.99.3.345","article-title":"Psychiatric disorders in adult patients with early-treated phenylketonuria","volume":"99","author":"Pietz","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1651-2227.1994.tb13467.x","article-title":"Psychopathology of patients treated early for phenylketonuria: results of the German collaborative study of phenylketonuria","volume":"407","author":"Burgard","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0245","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2012.11.003","article-title":"A diversified approach for PKU treatment: routine screening yields high incidence of psychiatric distress in phenylketonuria clinics","volume":"108","author":"Burton","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0250","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ymgme.2009.10.006","article-title":"Screening for cognitive and social\u2013emotional problems in individuals with PKU: tools for use in the metabolic clinic","volume":"99","author":"Waisbren","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0255","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1651-2227.1994.tb13463.x","article-title":"PKU in adolescents: rationale and psychosocial factors in diet continuation","volume":"407","author":"Levy","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2105\/AJPH.81.3.299","article-title":"Psychosocial factors in maternal phenylketonuria: prevention of unplanned pregnancies","volume":"81","author":"Waisbren","year":"1991","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0265","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.amjmed.2004.03.042","article-title":"Adult phenylketonuria","volume":"117","author":"Hanley","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0270","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/00019052-199812000-00012","article-title":"Neurological aspects of adult phenylketonuria","volume":"11","author":"Pietz","year":"1998","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0275","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1023\/A:1010546000617","article-title":"PKU adults and their return to diet: predicting diet continuation and maintenance","volume":"24","author":"Finkelson","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0280","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM198011203032104","article-title":"Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies","volume":"303","author":"Lenke","year":"1980","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/adc.2003.037762","article-title":"Maternal phenylketonuria: report from the United Kingdom Registry 1978\u201397","volume":"90","author":"Lee","year":"2005","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0290","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajcn\/88.3.700","article-title":"Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine","volume":"88","author":"Maillot","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0295","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3945\/ajcn.110.009456","article-title":"Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies","volume":"95","author":"Prick","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0300","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1093\/ajcn\/73.4.792","article-title":"Intake of major nutrients by women in the Maternal Phenylketonuria (MPKU) Study and effects on plasma phenylalanine concentrations","volume":"73","author":"Acosta","year":"2001","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0305","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1067\/mob.2002.124276","article-title":"Nutrient intake and congenital heart defects in maternal phenylketonuria","volume":"187","author":"Michals-Matalon","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0310","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpeds.2003.10.062","article-title":"Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6years: the importance of strict dietary control preconception and throughout pregnancy","volume":"144","author":"Rouse","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0315","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0002-9378(00)70219-5","article-title":"The international study of pregnancy outcome in women with maternal phenylketonuria: report of a 12-year study","volume":"182","author":"Platt","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0320","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10545-012-9491-0","article-title":"Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation","volume":"35","author":"Teissier","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0325","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1542\/peds.112.S4.1544","article-title":"Cognitive and behavioral development in maternal phenylketonuria offspring","volume":"112","author":"Waisbren","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0330","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/B:BOLI.0000028785.20901.d9","article-title":"The Resource Mothers Study of Maternal Phenylketonuria: preliminary findings","volume":"27","author":"Rohr","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0335","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00125817-200203000-00006","article-title":"Barriers to successful dietary control among pregnant women with phenylketonuria","volume":"4","author":"Brown","year":"2002","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0340","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jada.2009.10.030","article-title":"Perspectives on dietary adherence among women with inborn errors of metabolism","volume":"110","author":"Kemper","year":"2010","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0345","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1542\/peds.112.S4.1534","article-title":"Role of nutrition in pregnancy with phenylketonuria and birth defects","volume":"112","author":"Matalon","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0350","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0002-8223(21)09775-3","article-title":"Serum lipids in children with phenylketonuria (PKU)","volume":"63","author":"Acosta","year":"1973","journal-title":"J. Am. Diet. Assoc."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2014.02.013_bb0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01811492","article-title":"Plasma lipid concentrations in 42 treated phenylketonuric children","volume":"8","author":"Galluzzo","year":"1985","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0360","series-title":"Genetic Disorders and Pregnancy Outcome","first-page":"21","article-title":"Nutrition findings and requirements in pregnant women with phenylketonuria","author":"Acosta","year":"1997"},{"key":"10.1016\/j.ymgme.2014.02.013_rf0355","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1177\/15648265080292S114","article-title":"Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development","volume":"29","author":"Molloy","year":"2008","journal-title":"Food Nutr. Bull."},{"key":"10.1016\/j.ymgme.2014.02.013_or0015","unstructured":"(discussion S112-105)"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0370","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3945\/ajcn.2008.27280","article-title":"Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids","volume":"89","author":"van Calcar","year":"2009","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0375","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10545-007-0556-4","article-title":"Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine","volume":"30","author":"Matalon","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0380","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1097\/AOG.0b013e3181c6f93d","article-title":"ACOG committee opinion no. 449: maternal phenylketonuria","volume":"114","author":"C.o.G. American College of Obstetricians and Gynecologists","year":"2009","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0385","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-2007-999931","article-title":"Lactation and phenylketonuria","volume":"2","author":"Bradburn","year":"1985","journal-title":"Am. J. Perinatol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0390","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1177\/000992289703600908","article-title":"Maternal PKU and breastfeeding: case report of identical twin mothers","volume":"36","author":"Fox-Bacon","year":"1997","journal-title":"Clin. Pediatr. (Phila)"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0395","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00431-003-1182-2","article-title":"A different approach to breast-feeding of the infant with phenylketonuria","volume":"162","author":"van Rijn","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0400","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2217\/17455057.3.4.487","article-title":"Traditional postpartum practices and rituals: a qualitative systematic review","volume":"3","author":"Dennis","year":"2007","journal-title":"Womens Health (Lond. Engl.)"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0405","series-title":"Physicians' Desk Reference","author":"Staff","year":"2011"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0410","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.ymgme.2005.09.004","article-title":"Tetrahydrobiopterin and maternal PKU","volume":"86","author":"Koch","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0415","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1941406409344097","article-title":"Sapropterin dihydrochloride (6R-BH4) and maternal phenylketonuria two case studies","volume":"1","author":"Moselely","year":"2009","journal-title":"ICAN Infant Child Adolesc. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0420","series-title":"The American Society of Human Genetics 58th Annual Meeting, Philadelphia, PA","article-title":"PKU treatment with tetrahydrobiopterin (sapropterin) during pregnancy","author":"Pridjian","year":"2008"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0425","first-page":"3471","article-title":"Studies on metabolism and disposition of sapropterine hydrochloride (SUN-0588) l-erythro-tetrahydrobiopterin dichloride in rats","volume":"26","author":"Hayashi","year":"1992","journal-title":"Clin. Rep."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0430","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1203\/PDR.0b013e31820bc13a","article-title":"Tetrahydrobiopterin is present in high quantity in human milk and has a vasorelaxing effect on newborn rat mesenteric arteries","volume":"69","author":"Weinmann","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0435","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1651-2227.1994.tb13453.x","article-title":"Treatment of phenylalanine hydroxylase deficiency","volume":"407","author":"Smith","year":"1994","journal-title":"Acta Paediatr. Suppl."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0440","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/bmj.306.6870.115","article-title":"Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria","volume":"306","author":"M.R.C.W.P.o. Phenylketonuria","year":"1993","journal-title":"BMJ"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0445","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1007\/BF03036507","article-title":"Summary of findings from the United States Collaborative Study of children treated for phenylketonuria","volume":"155","author":"Azen","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0450","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/bmj.2.6139.723","article-title":"Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria","volume":"2","author":"Smith","year":"1978","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0455","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00477051","article-title":"Termination of dietary treatment in phenylketonuria","volume":"126","author":"Cabalska","year":"1977","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0460","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/adc.66.3.311","article-title":"Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria","volume":"66","author":"Smith","year":"1991","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0465","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1542\/peds.75.2.226","article-title":"Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction","volume":"75","author":"Seashore","year":"1985","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0470","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF01805813","article-title":"Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age","volume":"7","author":"Koch","year":"1984","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0475","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S0033291700013842","article-title":"Mental development of phenylketonuric children on or off diet after the age of six","volume":"6","author":"Brown","year":"1976","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0480","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1056\/NEJM198603063141001","article-title":"Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria","volume":"314","author":"Holtzman","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0485","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1067\/mjd.2003.261","article-title":"Cutaneous findings in a 51-year-old man with phenylketonuria","volume":"49","author":"Belloso","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0490","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-4362.1983.tb02163.x","article-title":"Pseudoscleroderma and phenylketonuria","volume":"22","author":"Guillet","year":"1983","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0495","first-page":"139","article-title":"Phenylketonuria with skin induration and atrophy (morphea, Pasini\u2013Pierini atroderma and subcutaneous atrophy)","volume":"5","author":"Szczepanski","year":"1995","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0500","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0190-9622(92)70048-K","article-title":"Scleroderma-like skin indurations in a child with phenylketonuria: a clinicopathologic correlation and review of the literature","volume":"26","author":"Nova","year":"1992","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0505","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/adc.74.5.412","article-title":"Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet","volume":"74","author":"MacDonald","year":"1996","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0510","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.92.4.570","article-title":"Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting\/postprandial) in patients with phenylketonuria: effect of sample timing","volume":"92","author":"van Spronsen","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0515","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1006\/mgme.2000.2985","article-title":"\u201cHypotyrosinemia\u201d in phenylketonuria","volume":"69","author":"Hanley","year":"2000","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2014.02.013_bb0520","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10545-010-9211-6","article-title":"Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey","volume":"33","author":"Sharman","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0525","series-title":"The Abbott Nutrition Metabolic Formula System Nutrition Support Protocols","author":"Abbott Nutrition","year":"2001"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0530","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/07315724.1999.10718836","article-title":"Protein status of infants with phenylketonuria undergoing nutrition management","volume":"18","author":"Acosta","year":"1999","journal-title":"J. Am. Coll. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0535","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ymgme.2011.05.011","article-title":"Effect of tetrahydrobiopterin on Phe\/Tyr ratios and variation in Phe levels in tetrahydrobiopterin responsive PKU patients","volume":"104","author":"Humphrey","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0540","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3476(86)80220-7","article-title":"A simple method for detection of heterozygous carriers of the gene for classic phenylketonuria","volume":"109","author":"Hilton","year":"1986","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0545","series-title":"APHL Newborn Screening and Genetics Testing Symposium, San Diego, CA","article-title":"PKU screening: simple idea, complex realities","author":"Weiss","year":"2011"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0550","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/1467-8624.00370","article-title":"Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria","volume":"72","author":"Luciana","year":"2001","journal-title":"Child Dev."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0555","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/87565640903325725","article-title":"A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of \u201csafe\u201d levels","volume":"35","author":"Sharman","year":"2010","journal-title":"Dev. Neuropsychol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0560","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00711748","article-title":"Physical growth in patients with phenylketonuria","volume":"18","author":"Dhondt","year":"1995","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0565","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1067\/mpd.2002.126455","article-title":"Protein insufficiency and linear growth restriction in phenylketonuria","volume":"141","author":"Arnold","year":"2002","journal-title":"J. Pediatr."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0570","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1007\/PL00014231","article-title":"Nutrition studies in treated infants and children with phenylketonuria: vitamins, minerals, trace elements","volume":"155","author":"Acosta","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0575","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0002-8223(03)00983-0","article-title":"Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy","volume":"103","author":"Acosta","year":"2003","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0580","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10545-007-0549-3","article-title":"Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature","volume":"30","author":"Huemer","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0585","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004703-198406000-00005","article-title":"Growth development and its relationship to intellectual functioning of children with phenylketonuria","volume":"5","author":"Chang","year":"1984","journal-title":"J. Dev. Behav. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0590","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ymgme.2011.08.002","article-title":"Physical development in patients with phenylketonuria on dietary treatment: a retrospective study","volume":"104","author":"Belanger-Quintana","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0595","series-title":"Adult Obesity Facts","author":"P.A. Division of Nutrition, and Obesity","year":"2013"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0600","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1111\/j.1651-2227.2004.tb00849.x","article-title":"Body mass index rebound and overweight at 8years of age in hyperphenylalaninaemic children","volume":"93","author":"Scaglioni","year":"2004","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0605","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.ymgme.2012.10.006","article-title":"Dietary treatment in phenylketonuria does not lead to increased risk of obesity or metabolic syndrome","volume":"107","author":"Rocha","year":"2012","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2014.02.013_bb0610","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10545-010-9149-8","article-title":"Whole body composition analysis by the BodPod air-displacement plethysmography method in children with phenylketonuria shows a higher body fat percentage","volume":"33","author":"Albersen","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0615","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/03014469100001662","article-title":"Physical growth of children treated for phenylketonuria","volume":"18","author":"McBurnie","year":"1991","journal-title":"Ann. Hum. Biol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jhn.12054","article-title":"Body mass index in adult patients with diet-treated phenylketonuria","volume":"26","author":"Robertson","year":"2013","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1024063726046","article-title":"Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria","volume":"26","author":"Dobbelaere","year":"2003","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0630","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3945\/ajcn.2009.28385","article-title":"Reference curves for triceps and subscapular skinfold thicknesses in US children and adolescents","volume":"91","author":"Addo","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0635","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1007\/PL00014227","article-title":"Recommendations for protein and energy intakes by patients with phenylketonuria","volume":"155","author":"Acosta","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0640","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000276641","article-title":"The use of prealbumin concentration as a biomarker of nutritional status in treated phenylketonuric patients","volume":"56","author":"Rocha","year":"2010","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0645","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/adc.2005.084285","article-title":"Protein substitute dosage in PKU: how much do young patients need?","volume":"91","author":"MacDonald","year":"2006","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0650","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00005176-199809000-00003","article-title":"Nutrient intake and growth of infants with phenylketonuria undergoing therapy","volume":"27","author":"Acosta","year":"1998","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0655","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.GIM.0000117335.50541.F3","article-title":"Iron status of children with phenylketonuria undergoing nutrition therapy assessed by transferrin receptors","volume":"6","author":"Acosta","year":"2004","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0660","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/07315724.2001.10719016","article-title":"Iron and protein sufficiency and red cell indices in phenylketonuria","volume":"20","author":"Arnold","year":"2001","journal-title":"J. Am. Coll. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0665","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1007\/PL00014232","article-title":"Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria","volume":"155","author":"Lombeck","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0670","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.nutres.2007.12.009","article-title":"Poor zinc and selenium status in phenylketonuric children and adolescents in Brazil","volume":"28","author":"Barretto","year":"2008","journal-title":"Nutr. Res."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0675","series-title":"Nutrition Management of Patients with Inherited Metabolic Disorders","article-title":"Evaluation of nutrition status","author":"Acosta","year":"2010"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0680","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ajcn\/59.2.419","article-title":"Decreased bone mineral density in children with phenylketonuria","volume":"59","author":"Allen","year":"1994","journal-title":"Am. J. Clin. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0685","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1007\/PL00014234","article-title":"Decreased bone mineralization in children with phenylketonuria under treatment","volume":"155","author":"Hillman","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0690","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/ajcn\/55.5.997","article-title":"Bone mineral status in children with phenylketonuria\u2014relationship to nutritional intake and phenylalanine control","volume":"55","author":"McMurry","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0695","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00005176-200109000-00005","article-title":"Intake and blood levels of fatty acids in treated patients with phenylketonuria","volume":"33","author":"Acosta","year":"2001","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0700","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1017\/S0012162206000442","article-title":"A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria","volume":"48","author":"Agostoni","year":"2006","journal-title":"Dev. Med. Child Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0705","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1007\/PL00014230","article-title":"Fatty acid metabolism in phenylketonuria","volume":"155","author":"Giovannini","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0710","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.ejcn.1602401","article-title":"Randomised controlled trial of essential fatty acid supplementation in phenylketonuria","volume":"60","author":"Cleary","year":"2006","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0715","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jpeds.2006.12.011","article-title":"Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria","volume":"150","author":"Beblo","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0720","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-277X.2005.00643.x","article-title":"Fat intakes of children with PKU on low phenylalanine diets","volume":"18","author":"Rose","year":"2005","journal-title":"J. Hum. Nutr. Diet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0725","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2165\/11594130-000000000-00000","article-title":"Vitamins and cognition: what is the evidence?","volume":"71","author":"Kennedy","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0730","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1037\/0894-4105.22.4.426","article-title":"Cognitive functions and the antioxidant system in phenylketonuric patients","volume":"22","author":"Gassio","year":"2008","journal-title":"Neuropsychology"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0735","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.ymgme.2011.09.015","article-title":"Specific prebiotics in a formula for infants with phenylketonuria","volume":"104","author":"MacDonald","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0740","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1542\/peds.97.6.839","article-title":"Phenylketonuria: plasma phenylalanine responses to different distributions of the daily phenylalanine allowance over the day","volume":"97","author":"van Spronsen","year":"1996","journal-title":"Pediatrics"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0745","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1007\/PL00014228","article-title":"Recommendations for protein and amino acid intake in phenylketonuric patients","volume":"155","author":"Cockburn","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0750","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymgme.2009.07.016","article-title":"Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes","volume":"98","author":"MacLeod","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0755","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2007.09.017","article-title":"Recommendations for evaluation of responsiveness to tetrahydrobiopterin (BH(4)) in phenylketonuria and its use in treatment","volume":"92","author":"Levy","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0760","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ymgme.2009.01.002","article-title":"Optimizing the use of sapropterin (BH(4)) in the management of phenylketonuria","volume":"96","author":"Blau","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0765","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10545-008-0947-1","article-title":"Effect of BH(4) supplementation on phenylalanine tolerance","volume":"32","author":"Burlina","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0770","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10545-007-0552-8","article-title":"Phenylketonuria: dietary and therapeutic challenges","volume":"30","author":"Giovannini","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0775","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0780","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(07)61234-3","article-title":"Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomised placebo-controlled study","volume":"370","author":"Levy","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0785","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.ymgme.2005.07.024","article-title":"Spanish BH4-responsive phenylalanine hydroxylase-deficient patients: evolution of seven patients on long-term treatment with tetrahydrobiopterin","volume":"86","author":"Belanger-Quintana","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0790","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s10545-007-0651-6","article-title":"Effects and clinical significance of tetrahydrobiopterin supplementation in phenylalanine hydroxylase-deficient hyperphenylalaninaemia","volume":"30","author":"Gramer","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0795","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ymgme.2011.08.009","article-title":"Up to date knowledge on different treatment strategies for phenylketonuria","volume":"104","author":"Belanger-Quintana","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0800","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1440-1754.2006.00909.x","article-title":"Three-year audit of the hyperphenylalaninaemia\/phenylketonuria spectrum in Victoria","volume":"42","author":"Boneh","year":"2006","journal-title":"J. Paediatr. Child Health"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0805","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.ymgme.2005.05.014","article-title":"Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapy","volume":"86","author":"Lambruschini","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0810","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ymgme.2011.03.020","article-title":"Safety of extended treatment with sapropterin dihydrochloride in patients with phenylketonuria: results of a phase 3b study","volume":"103","author":"Burton","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0815","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ymgme.2011.09.009","article-title":"Using change in plasma phenylalanine concentrations and ability to liberalize diet to classify responsiveness to tetrahydrobiopterin therapy in patients with phenylketonuria","volume":"104","author":"Singh","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0820","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.TIN.0000318911.54358.a1","article-title":"Recommendations for personalized dietary adjustments based on patient response to tetrahydrobiopterin (BH4) in phenylketonuria","volume":"23","author":"Singh","year":"2008","journal-title":"Top. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0825","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpeds.2008.11.040","article-title":"Efficacy of sapropterin dihydrochloride in increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized, double-blind, placebo-controlled study","volume":"154","author":"Trefz","year":"2009","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0830","first-page":"1","article-title":"Adjusting diet with sapropterin in phenylketonuria: what factors should be considered?","author":"Macdonald","year":"2011","journal-title":"Br. J. Nutr."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb0835","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2005.05.013","article-title":"Long-term treatment with tetrahydrobiopterin increases phenylalanine tolerance in children with severe phenotype of phenylketonuria","volume":"86","author":"Hennermann","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0840","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2012.04.004","article-title":"Recommendations for the use of sapropterin in phenylketonuria","volume":"106","author":"Cunningham","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0845","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrendo.2010.125","article-title":"Phenylketonuria: a 21st century perspective","volume":"6","author":"van Spronsen","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0850","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/archneur.1976.00500100018008","article-title":"Lowering brain phenylalanine levels by giving other large neutral amino acids. A new experimental therapeutic approach to phenylketonuria","volume":"33","author":"Andersen","year":"1976","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0855","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1172\/JCI5017","article-title":"Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria","volume":"103","author":"Pietz","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0860","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1023\/A:1022482604276","article-title":"Blood\u2013brain barrier carrier-mediated transport and brain metabolism of amino acids","volume":"23","author":"Pardridge","year":"1998","journal-title":"Neurochem. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2014.02.013_bb0865","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1007\/PL00014370","article-title":"The neurochemistry of phenylketonuria","volume":"159","author":"Surtees","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0870","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2007.02.002","article-title":"The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study","volume":"91","author":"Schindeler","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0875","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1542\/peds.112.S4.1575","article-title":"Brain phenylalanine concentrations in phenylketonuria: research and treatment of adults","volume":"112","author":"Moats","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0880","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1093\/jn\/130.11.2780","article-title":"Transport mechanisms of the large neutral amino acid l-phenylalanine in the human intestinal epithelial caco-2 cell line","volume":"130","author":"Berger","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0885","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1007\/s10545-006-0395-8","article-title":"Large neutral amino acids in the treatment of phenylketonuria (PKU)","volume":"29","author":"Matalon","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0890","first-page":"51","article-title":"Effects of diet discontinuation and dietary tryptophan supplementation on neurotransmitter metabolism in phenylketonuria","volume":"1","author":"Nielsen","year":"1988","journal-title":"Brain Dysfunct."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0895","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(85)90250-8","article-title":"Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria","volume":"2","author":"Lou","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0900","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1651-2227.1994.tb13025.x","article-title":"Unchanged MRI of myelin in adolescents with PKU supplied with non-phe essential amino acids after dietary relaxation","volume":"83","author":"Lou","year":"1994","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0905","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/j.1651-2227.2005.tb02078.x","article-title":"Behavioural effects of phenylalanine-free amino acid tablet supplementation in intellectually disabled adults with untreated phenylketonuria","volume":"94","author":"Kalkanoglu","year":"2005","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0910","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10545-010-9216-1","article-title":"Large neutral amino acids in the treatment of PKU: from theory to practice","volume":"33","author":"van Spronsen","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2014.02.013_bb0915","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1007\/s10545-010-9069-7","article-title":"Large neutral amino acids in daily practice","volume":"33","author":"Ahring","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0920","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10545-008-0952-4","article-title":"Nutritional management of PKU with glycomacropeptide from cheese whey","volume":"32","author":"Ney","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0925","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ymgme.2007.06.004","article-title":"Acceptable low-phenylalanine foods and beverages can be made with glycomacropeptide from cheese whey for individuals with PKU","volume":"92","author":"Lim","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0930","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/jn\/138.2.316","article-title":"Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria","volume":"138","author":"Ney","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0935","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ymgme.2010.04.003","article-title":"Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria","volume":"100","author":"MacLeod","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0940","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ymgme.2011.08.017","article-title":"Diagnosis, classification, and genetics of phenylketonuria and tetrahydrobiopterin (BH4) deficiencies","volume":"104","author":"Blau","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0945","first-page":"1","article-title":"Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood","volume":"280","author":"Guttler","year":"1980","journal-title":"Acta Paediatr. Scand. Suppl."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0950","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10545-008-0937-3","article-title":"Phenylalanine tolerance can already reliably be assessed at the age of 2years in patients with PKU","volume":"32","author":"van Spronsen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0955","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1203\/00006450-199911000-00017","article-title":"Molecular correlations in phenylketonuria: mutation patterns and corresponding biochemical and clinical phenotypes in a heterogeneous California population","volume":"46","author":"Enns","year":"1999","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4238\/vol9-1gmr670","article-title":"Variations in genotype\u2013phenotype correlations in phenylketonuria patients","volume":"9","author":"Santos","year":"2010","journal-title":"Genet. Mol. Res."},{"issue":"Suppl. 2","key":"10.1016\/j.ymgme.2014.02.013_bb0965","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1007\/PL00014382","article-title":"PAH gene mutation analysis in clinical practice\u2014comments on mutation analysis anticipates dietary requirements in phenylketonuria","volume":"159","author":"Zschocke","year":"2000","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0970","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jmg.30.5.401","article-title":"Comparison of genotype and intellectual phenotype in untreated PKU patients","volume":"30","author":"Ramus","year":"1993","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0975","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/BF02072490","article-title":"Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients","volume":"152","author":"Svensson","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0980","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1086\/301920","article-title":"A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype","volume":"63","author":"Guldberg","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb0985","first-page":"512","article-title":"Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population","volume":"97","author":"Eisensmith","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0990","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2014.02.013_bb0995","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1440-1754.1991.tb00384.x","article-title":"The natural history of untreated phenylketonuria over 20years","volume":"27","author":"Pitt","year":"1991","journal-title":"J. Paediatr. Child Health"},{"issue":"Pt 1","key":"10.1016\/j.ymgme.2014.02.013_bb1000","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2788.2000.00260.x","article-title":"An investigation into diet treatment for adults with previously untreated phenylketonuria and severe intellectual disability","volume":"44","author":"Fitzgerald","year":"2000","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1005","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/jnnp.2008.151175","article-title":"Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet","volume":"80","author":"Lee","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1467-8624.2009.01389.x","article-title":"Late-treated phenylketonuria and partial reversibility of intellectual impairment","volume":"81","author":"Grosse","year":"2010","journal-title":"Child Dev."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1015","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1042\/BJ20110293","article-title":"Tetrahydrobiopterin: biochemistry and pathophysiology","volume":"438","author":"Werner","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3476(99)70138-1","article-title":"Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"135","author":"Kure","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1025","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jpeds.2007.02.017","article-title":"Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria","volume":"150","author":"Fiege","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2004.03.006","article-title":"The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"82","author":"Blau","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/humu.20097","article-title":"Mechanisms underlying responsiveness to tetrahydrobiopterin in mild phenylketonuria mutations","volume":"24","author":"Pey","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1040","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1093\/hmg\/ddr165","article-title":"The interplay between genotype, metabolic state and cofactor treatment governs phenylalanine hydroxylase function and drug response","volume":"20","author":"Staudigl","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/humu.22320","article-title":"Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria","volume":"34","author":"Heintz","year":"2013","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1050","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ymgme.2004.06.016","article-title":"Wild-type phenylalanine hydroxylase activity is enhanced by tetrahydrobiopterin supplementation in vivo: an implication for therapeutic basis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"83","author":"Kure","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1055","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa021654","article-title":"Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria","volume":"347","author":"Muntau","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1060","first-page":"335","article-title":"Screening and diagnosis of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency with tetrahydrobiopterin loading test","volume":"43","author":"Zhang","year":"2005","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ymgme.2009.03.009","article-title":"Genotype-predicted tetrahydrobiopterin (BH4)-responsiveness and molecular genetics in Croatian patients with phenylalanine hydroxylase (PAH) deficiency","volume":"97","author":"Karacic","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/humu.20637","article-title":"Molecular genetics of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"29","author":"Zurfluh","year":"2008","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1075","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2010.11.158","article-title":"Molecular genetics and impact of residual in vitro phenylalanine hydroxylase activity on tetrahydrobiopterin responsiveness in Turkish PKU population","volume":"102","author":"Dobrowolski","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1080","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ymgme.2011.10.014","article-title":"START, a double blind, placebo-controlled pharmacogenetic test of responsiveness to sapropterin dihydrochloride in phenylketonuria patients","volume":"105","author":"Utz","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1085","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"1725","article-title":"Disorders of tetrahydrobiopterin and related biogenic amines","author":"Blau","year":"2001"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1090","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1098-1004(1997)10:1<11::AID-HUMU2>3.0.CO;2-P","article-title":"Mutations in the GTP cyclohydrolase I and 6-pyruvoyl-tetrahydropterin synthase genes","volume":"10","author":"Thony","year":"1997","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s004390050800","article-title":"Mutations in the pterin-4alpha-carbinolamine dehydratase (PCBD) gene cause a benign form of hyperphenylalaninemia","volume":"103","author":"Thony","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1098-1004(1998)12:4<267::AID-HUMU8>3.0.CO;2-C","article-title":"Dihydropteridine reductase deficiency: physical structure of the QDPR gene, identification of two new mutations and genotype\u2013phenotype correlations","volume":"12","author":"Dianzani","year":"1998","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1086\/321970","article-title":"Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia","volume":"69","author":"Bonafe","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1110","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/mgme.2001.3213","article-title":"Tetrahydrobiopterin deficiencies without hyperphenylalaninemia: diagnosis and genetics of dopa-responsive dystonia and sepiapterin reductase deficiency","volume":"74","author":"Blau","year":"2001","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1115","doi-asserted-by":"crossref","first-page":"24657","DOI":"10.1016\/S0021-9258(17)31441-2","article-title":"Regulation of rat liver phenylalanine hydroxylase. III. Control of catalysis by (6R)-tetrahydrobiopterin and phenylalanine","volume":"269","author":"Xia","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1120","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1046\/j.1471-4159.1995.64062810.x","article-title":"Monoaminergic effects of folinic acid, L-DOPA, and 5-hydroxytryptophan in dihydropteridine reductase deficiency","volume":"64","author":"Goldstein","year":"1995","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1125","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.bcp.2010.07.042","article-title":"New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1\/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"80","author":"Lagler","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ymgme.2003.09.014","article-title":"Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration","volume":"81","author":"Fiege","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1135","series-title":"Concepts in Clinical Pharmacokinetics","author":"DiPiro","year":"2010"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1140","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.earlhumdev.2008.01.003","article-title":"Evaluation of neonatal BH4 loading test in neonates screened for hyperphenylalaninemia","volume":"84","author":"Feillet","year":"2008","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003495-200969040-00006","article-title":"Sapropterin: a review of its use in the treatment of primary hyperphenylalaninaemia","volume":"69","author":"Sanford","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1150","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1002\/ajmg.a.32562","article-title":"Safety and efficacy of 22weeks of treatment with sapropterin dihydrochloride in patients with phenylketonuria","volume":"146A","author":"Lee","year":"2008","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1155","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10545-006-0425-6","article-title":"Pharmacokinetics of orally administered tetrahydrobiopterin in patients with phenylalanine hydroxylase deficiency","volume":"29","author":"Zurfluh","year":"2006","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1160","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2165\/0003088-200847120-00006","article-title":"Pharmacokinetics of sapropterin in patients with phenylketonuria","volume":"47","author":"Feillet","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1165","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1093\/hmg\/ddq085","article-title":"Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo","volume":"19","author":"Gersting","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1170","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1345\/aph.1M050","article-title":"Sapropterin: a new therapeutic agent for phenylketonuria","volume":"43","author":"Hegge","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s10545-008-0966-y","article-title":"PKU\u2014what is daily practice in various centres in Europe? Data from a questionnaire by the scientific advisory committee of the European Society of Phenylketonuria and Allied Disorders","volume":"32","author":"van Spronsen","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1180","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2009.09.005","article-title":"Management of phenylketonuria in Europe: survey results from 19 countries","volume":"99","author":"Blau","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1185","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1203\/00006450-200104000-00015","article-title":"Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia","volume":"49","author":"Weglage","year":"2001","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1190","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ymgme.2010.12.003","article-title":"The effect of blood phenylalanine concentration on Kuvan response in phenylketonuria","volume":"102","author":"Elsas","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1195","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s10545-008-0940-8","article-title":"Significance of genotype in tetrahydrobiopterin-responsive phenylketonuria","volume":"32","author":"Trefz","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1200","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s10545-007-9979-1","article-title":"Defining tetrahydrobiopterin (BH4)-responsiveness in PKU","volume":"31","author":"Blau","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1205","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1399-0004.2009.01306.x","article-title":"Phenotypic variability, neurological outcome and genetics background of 6-pyruvoyl-tetrahydropterin synthase deficiency","volume":"77","author":"Leuzzi","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1210","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s10545-009-1070-7","article-title":"Blood phenylalanine concentrations in patients with PAH-deficient hyperphenylalaninaemia off diet without and with three different single oral doses of tetrahydrobiopterin: assessing responsiveness in a model of statistical process control","volume":"32","author":"Lindner","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1215","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10545-010-9224-1","article-title":"BH(4) therapy impacts the nutrition status and intake in children with phenylketonuria: 2-year follow-up","volume":"33","author":"Singh","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1220","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ymgme.2013.07.010","article-title":"White matter integrity and executive abilities following treatment with tetrahydrobiopterin (BH4) in individuals with phenylketonuria","volume":"110","author":"White","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1225","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clinthera.2010.02.012","article-title":"Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults","volume":"32","author":"Musson","year":"2010","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1230","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.ymgme.2011.09.024","article-title":"The 48-hour tetrahydrobiopterin loading test in patients with phenylketonuria: evaluation of protocol and influence of baseline phenylalanine concentration","volume":"104","author":"Anjema","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10545-009-9002-0","article-title":"Tetrahydrobiopterin responsiveness after extended loading test of 12 Danish PKU patients with the Y414C mutation","volume":"33","author":"Nielsen","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ymgme.2011.04.014","article-title":"Blood phenylalanine clearance and BH(4)-responsiveness in classic phenylketonuria","volume":"103","author":"Bik-Multanowski","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1245","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0009-8981(86)90301-3","article-title":"Metabolic conversion of l-[U-14C]phenylalanine to respiratory 14CO2 in healthy subjects, phenylketonuria heterozygotes and classic phenylketonurics","volume":"157","author":"Lehmann","year":"1986","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1250","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1203\/00006450-199710000-00002","article-title":"Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using l-[1-13C]phenylalanine oxidation rates in vivo: a pilot study","volume":"42","author":"Treacy","year":"1997","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1255","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1203\/01.PDR.0000141520.06524.51","article-title":"In vivo studies of phenylalanine hydroxylase by phenylalanine breath test: diagnosis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency","volume":"56","author":"Okano","year":"2004","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1260","doi-asserted-by":"crossref","first-page":"16903","DOI":"10.1073\/pnas.0407256101","article-title":"Correction of kinetic and stability defects by tetrahydrobiopterin in phenylketonuria patients with certain phenylalanine hydroxylase mutations","volume":"101","author":"Erlandsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10545-009-9967-8","article-title":"Tetrahydrobiopterin in biomedical research","volume":"32","author":"Blau","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.GIM.0000108840.17922.A7","article-title":"Biopterin responsive phenylalanine hydroxylase deficiency","volume":"6","author":"Matalon","year":"2004","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1275","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ymgme.2010.03.022","article-title":"Introduction of sapropterin dihydrochloride as standard of care in patients with phenylketonuria","volume":"100","author":"Vernon","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1280","series-title":"BioMarin Kuvan Package Insert","author":"BioMarin","year":"2007"},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb1285","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/j.ymgme.2005.09.014","article-title":"Extended tetrahydrobiopterin loading test in the diagnosis of cofactor-responsive phenylketonuria: a pilot study","volume":"86","author":"Fiege","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1290","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10545-012-9506-x","article-title":"An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia","volume":"35","author":"Opladen","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1295","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jpeds.2010.08.016","article-title":"Tetrahydrobiopterin therapy for phenylketonuria in infants and young children","volume":"158","author":"Burton","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1300","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/mgme.1999.2863","article-title":"Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuria","volume":"67","author":"Koch","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1305","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/mgme.2001.3289","article-title":"Mental illness in mild PKU responds to biopterin","volume":"75","author":"Koch","year":"2002","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb1310","first-page":"S1","article-title":"Pilot Study to Evaluate the Effects of Sapropterin on Adult Individuals with Phenylketonuria with Measurable Maladaptive Behaviors","volume":"33","author":"Yano","year":"2010","journal-title":"J. Inherit Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1315","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2013.10","article-title":"Newborn screening 50years later: access issues faced by adults with PKU","volume":"15","author":"Berry","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1320","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJM199105023241802","article-title":"Molecular basis of phenotypic heterogeneity in phenylketonuria","volume":"324","author":"Okano","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1325","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/bi00324a002","article-title":"Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase","volume":"24","author":"Kwok","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1330","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/GIM.0b013e3182141b48","article-title":"Phenylalanine hydroxylase deficiency","volume":"13","author":"Mitchell","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1335","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/8904_2011_96","article-title":"Chaperone-like therapy with tetrahydrobiopterin in clinical trials for phenylketonuria: is genotype a predictor of response?","volume":"5","author":"Sarkissian","year":"2012","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1340","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ymgme.2007.03.010","article-title":"Mutations in the phenylalanine hydroxylase gene identified in 95 patients with phenylketonuria using novel systems of mutation scanning and specific genotyping based upon thermal melt profiles","volume":"91","author":"Dobrowolski","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1345","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/jhg.2009.37","article-title":"A limited spectrum of phenylalanine hydroxylase mutations is observed in phenylketonuria patients in western Poland and implications for treatment with 6R tetrahydrobiopterin","volume":"54","author":"Dobrowolski","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1350","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/humu.9113","article-title":"The molecular basis of phenylketonuria in Lithuania","volume":"21","author":"Kasnauskiene","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1355","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1023\/A:1005315106604","article-title":"Phenylketonuria in Italy: distinct distribution pattern of three mutations of the phenylalanine hydroxylase gene","volume":"20","author":"Guzzetta","year":"1997","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1360","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2009.09.002","article-title":"Converting an injectable protein therapeutic into an oral form: phenylalanine ammonia lyase for phenylketonuria","volume":"99","author":"Kang","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1365","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymgme.2011.06.016","article-title":"Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria","volume":"104","author":"Sarkissian","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1370","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1515\/cclm.2010.271","article-title":"l-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods","volume":"48","author":"De Silva","year":"2010","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1375","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10545-008-0942-6","article-title":"Biochemical characterization of mutant phenylalanine hydroxylase enzymes and correlation with clinical presentation in hyperphenylalaninaemic patients","volume":"32","author":"Dobrowolski","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1380","doi-asserted-by":"crossref","first-page":"12087","DOI":"10.1021\/bi8015263","article-title":"Crystal structure of tryptophan hydroxylase with bound amino acid substrate","volume":"47","author":"Windahl","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1385","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1399-0004.2008.01027.x","article-title":"Progress toward cell-directed therapy for phenylketonuria","volume":"74","author":"Harding","year":"2008","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1390","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1542\/peds.2009-3584","article-title":"Challenges and pitfalls in the management of phenylketonuria","volume":"126","author":"Feillet","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1395","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM199307293290517","article-title":"Correction of phenylketonuria after liver transplantation in a child with cirrhosis","volume":"329","author":"Vajro","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1400","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10545-010-9099-1","article-title":"Therapeutic liver repopulation for phenylketonuria","volume":"33","author":"Harding","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1405","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1084952102001313","article-title":"Principles of hepatocyte repopulation","volume":"13","author":"Laconi","year":"2002","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1410","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ymthe.2005.03.025","article-title":"Low therapeutic threshold for hepatocyte replacement in murine phenylketonuria","volume":"12","author":"Hamman","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1415","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2011.07.027","article-title":"Hepatocytes from wild-type or heterozygous donors are equally effective in achieving successful therapeutic liver repopulation in murine phenylketonuria (PKU)","volume":"104","author":"Hamman","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1420","first-page":"247","article-title":"Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer","volume":"1","author":"Fang","year":"1994","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1425","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/gt.2008.64","article-title":"Potential of AAV vectors in the treatment of metabolic disease","volume":"15","author":"Alexander","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1430","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/sj.gt.3302678","article-title":"Complete correction of hyperphenylalaninemia following liver-directed, recombinant AAV2\/8 vector-mediated gene therapy in murine phenylketonuria","volume":"13","author":"Harding","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1435","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.gt.3302684","article-title":"Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer","volume":"13","author":"Ding","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1440","first-page":"114","article-title":"Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a self-complementary adeno-associated virus vector","volume":"13","author":"Yagi","year":"2011","journal-title":"J. Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1445","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/hum.2009.127","article-title":"Comparison of adeno-associated virus pseudotype 1, 2, and 8 vectors administered by intramuscular injection in the treatment of murine phenylketonuria","volume":"21","author":"Rebuffat","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1450","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S1525-0016(16)35942-1","article-title":"Liver gene therapy for PKU using naked DNA\/minicircle vectors expressing phenylalanine hydroxylase from a synthetic minigene","volume":"20","author":"Viecelli","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1455","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/mt.2008.17","article-title":"Correction of murine PKU following AAV-mediated intramuscular expression of a complete phenylalanine hydroxylating system","volume":"16","author":"Ding","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1460","doi-asserted-by":"crossref","first-page":"23402","DOI":"10.1074\/jbc.M703367200","article-title":"A novel approach for enzyme replacement therapy. The use of phenylalanine hydroxylase-based fusion proteins for the treatment of phenylketonuria","volume":"282","author":"Eavri","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1465","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ymthe.2003.11.002","article-title":"Toward PKU enzyme replacement therapy: PEGylation with activity retention for three forms of recombinant phenylalanine hydroxylase","volume":"9","author":"Gamez","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1470","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1073\/pnas.96.5.2339","article-title":"A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase","volume":"96","author":"Sarkissian","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1475","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ymthe.2005.02.013","article-title":"Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria","volume":"11","author":"Gamez","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1480","doi-asserted-by":"crossref","first-page":"20894","DOI":"10.1073\/pnas.0808421105","article-title":"Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria","volume":"105","author":"Sarkissian","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1485","article-title":"Phase I trial of subcutaneous rAvPAL-PEG in subjects with phenylketonuria","author":"Longo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1490","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/1054-139X(93)90143-D","article-title":"Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine","volume":"14","author":"Blum","year":"1993","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1495","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1542\/peds.2011-0969","article-title":"Supporting the health care transition from adolescence to adulthood in the medical home","volume":"128","author":"Cooley","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1500","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1542\/peds.2010-3017","article-title":"Receipt of health care transition counseling in the national survey of adult transition and health","volume":"128","author":"Sawicki","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1505","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00431-010-1364-7","article-title":"Transition from pediatric to adult health care: expectations of adolescents with chronic disorders and their parents","volume":"170","author":"Rutishauser","year":"2011","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1510","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s10545-011-9284-x","article-title":"Transition of young adults with phenylketonuria from pediatric to adult care","volume":"34","author":"Mutze","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"issue":"Suppl. 5","key":"10.1016\/j.ymgme.2014.02.013_bb1515","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1528-1167.2011.03179.x","article-title":"Strategies for transitioning to adult care for youth with Lennox\u2013Gastaut syndrome and related disorders","volume":"52","author":"Camfield","year":"2011","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.ymgme.2014.02.013_bb1520","doi-asserted-by":"crossref","first-page":"S190","DOI":"10.1542\/peds.2010-1466P","article-title":"Residency training in transition of youth with childhood-onset chronic disease","volume":"126","author":"Patel","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1525","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1136\/adc.2010.202473","article-title":"Improving the transition between paediatric and adult healthcare: a systematic review","volume":"96","author":"Crowley","year":"2011","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1530","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00467-011-1980-0","article-title":"Utility and cost of a renal transplant transition clinic","volume":"27","author":"Prestidge","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1535","unstructured":"U.S. Congress, Orphan Drug Act, Pub. L. 97-414. 96 Stat. 2049 (1983). Amended in 1984 by Pub. L. 98-551 to add a numeric prevalence threshold to the definition of rare diseases, 1983."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1540","series-title":"Code of Federal Regulations","article-title":"Approval of an application and an abbreviated application","author":"U.S.F.a.D.A. (FDA)","year":"2013"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1545","series-title":"Guidance for Industry, Providing Clinical Evidence of Effectiveness for Human Drugs and Biological Products","author":"U.S.F.D.A. (FDA)","year":"1998"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1550","unstructured":"U.S. Congress, Federal Food, Drug and Cosmetic Act (FD&C Act), Section 505(d) [21 USC \u00a7355]. New drugs. As amended through December 31, 2004."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1555","series-title":"Adequate and Well-controlled Studies","author":"U.S.F.D.A. (FDA)","year":"2010"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1560","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10545-010-9185-4","article-title":"Phenylketonuria as a model for protein misfolding diseases and for the development of next generation orphan drugs for patients with inborn errors of metabolism","volume":"33","author":"Muntau","year":"2010","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1565","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.gene.2013.03.004","article-title":"Molecular epidemiology and BH4-responsiveness in patients with phenylalanine hydroxylase deficiency from Galicia region of Spain","volume":"521","author":"Couce","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1570","series-title":"Kuvan\u00ae (Sapropterin Dihydrochloride) Tablets for PKU","author":"B.P. Inc.","year":"2013"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1575","series-title":"Cross-discipline Team Leader Summary Review of NDA 22-181","author":"C.f.D.E.a.R. U.S. Food and Drug Administration (FDA)","year":"2007"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1580","series-title":"NDA Approval Letter, NDA 22-181","author":"F.D.A. U.S. Department of Health and Human Services","year":"2007"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1585","series-title":"Adjuvant Treatment for Phenylketonuria: Future Research Needs, Identification of Future Research Needs from Comparative Effectiveness Review No. 56","author":"McPheeters","year":"2012"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1590","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/genetics\/134.4.1205","article-title":"Mouse models of human phenylketonuria","volume":"134","author":"Shedlovsky","year":"1993","journal-title":"Genetics"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1595","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1073\/pnas.87.5.1965","article-title":"Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase","volume":"87","author":"McDonald","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1600","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ymgme.2013.03.020","article-title":"White matter integrity and executive abilities in individuals with phenylketonuria","volume":"109","author":"Antenor-Dorsey","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1605","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/mrm.21983","article-title":"Reproducibility of cerebral phenylalanine levels in patients with phenylketonuria determined by 1H-MR spectroscopy","volume":"62","author":"Kreis","year":"2009","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1610","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2012.12.008","article-title":"Risk factors for developing mineral bone disease in phenylketonuric patients","volume":"108","author":"Miras","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1615","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gim.2013.179","article-title":"Recommendations for the nutrition management of phenylalanine hydroxylase deficiency","volume":"16","author":"Singh","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1620","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1625","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/GIM.0b013e3181deb2f0","article-title":"Medical foods: inborn errors of metabolism and the reimbursement dilemma","volume":"12","author":"Weaver","year":"2010","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1630","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/TIN.0b013e3181c622e2","article-title":"Medical food for treatment of inborn errors of metabolism and state legislative mandates","volume":"24","author":"Huntington","year":"2009","journal-title":"Top. Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1635","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10964-010-9606-6","article-title":"Examining the light and dark sides of emerging adults' identity: a study of identity status differences in positive and negative psychosocial functioning","volume":"40","author":"Schwartz","year":"2011","journal-title":"J. Youth Adolesc."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1640","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clnu.2011.09.001","article-title":"Optimising growth in phenylketonuria: current state of the clinical evidence base","volume":"31","author":"Dokoupil","year":"2012","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1645","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.ymgme.2011.08.023","article-title":"Nutrition in phenylketonuria","volume":"104","author":"MacDonald","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1650","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/gim.2012.153","article-title":"Achieving the \u201ctriple aim\u201d for inborn errors of metabolism: a review of challenges to outcomes research and presentation of a new practice-based evidence framework","volume":"15","author":"Potter","year":"2013","journal-title":"Genet. Med"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1655","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1042\/bst0130436","article-title":"On the mechanism of action of phenylalanine hydroxylase","volume":"13","author":"Benkovic","year":"1985","journal-title":"Biochem. Soc. Trans."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2014.02.013_bb1660","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1007\/PL00014253","article-title":"The influence of mutations of enzyme activity and phenylalanine tolerance in phenylalanine hydroxylase deficiency","volume":"155","author":"Guttler","year":"1996","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1665","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/0026-0495(85)90112-X","article-title":"Normal plasma free amino acid values in adults: the influence of some common physiological variables","volume":"34","author":"Scriver","year":"1985","journal-title":"Metabolism"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1670","series-title":"PKU and BH4 Advances in Phenylketonuria and Tetrahydrobiopterin","first-page":"84","article-title":"Classification of PKU","author":"Marsden","year":"2006"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1675","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/clinchem\/44.12.2405","article-title":"Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24hours","volume":"44","author":"Chace","year":"1998","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1680","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","article-title":"Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project","volume":"13","author":"McHugh","year":"2011","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1685","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/gim.2012.2","article-title":"Enhanced interpretation of newborn screening results without analyte cutoff values","volume":"14","author":"Marquardt","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1690","series-title":"Ross Metabolic Formula System: Nutrition Support Protocols","author":"Acosta","year":"1997"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1695","series-title":"Nutrition Management of Patients with Inherited Metabolic Disorders","first-page":"126","article-title":"Nutrition management of patients with inherited metabolic disorders of aromatic amino acid metabolism","author":"Acosta","year":"2010"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1700","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S1096-7192(02)00171-3","article-title":"High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1,919 patients observed from 1988 to 2002","volume":"77","author":"Bernegger","year":"2002","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2014.02.013_bb1705","series-title":"Bayley Scales of Infant and Toddler Development\u00ae, Third Edition (Bayley-III\u00ae)","author":"Bayley","year":"2005"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1710","series-title":"Wechsler Preschool and Primary Scale of Intelligence\u2014Third Edition (WPPSI-III)","author":"Wechsler","year":"2002"},{"key":"10.1016\/j.ymgme.2014.02.013_bb1715","series-title":"Wechsler Abbreviated Scale of Intelligence (WASI)","author":"Wechsler","year":"1999"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214000857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719214000857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:03:05Z","timestamp":1648533785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719214000857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":344,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S1096719214000857"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2014.02.013","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}